-
Onslaught of eye medicine!
Time of Update: 2022-05-01
Among the new ophthalmic drugs currently under development by the company, KH906 eye drops, a class 1 new drug, has entered Phase I clinical trials for the treatment of corneal neovascularization; KH737 eye drops, which have been approved for clinical use, are used to delay the progression of myopia in children .
-
The purchase of basic infusion tapes in Heilongjiang Province has started!
Time of Update: 2022-05-01
The applicant enterprise must meet the following conditions: (1) Listed drugs that fall within the scope of the catalogue of purchased varieties and have obtained a valid domestic registration approval document .
-
Four departments jointly issued a document to promote mutual recognition of inspection results in medical institutions
Time of Update: 2022-05-01
The method divides the responsibilities of relevant departments, and clearly states that medical institutions should follow the principle of "guaranteeing quality and safety as the bottom line, taking quality control as the premise, reducing the burden on patients as the guide, meeting the needs of diagnosis and treatment as the foundation, and taking the judgment of the receiving physician as the basis.
-
CDE's new regulations speed up the launch of innovative drugs!
Time of Update: 2022-05-01
From the relevant requirements of the "Working Procedures", we can see that CDE strengthens the communication of the whole process, improves the efficiency of completing clinical trials, and focuses on supporting and accelerating the specific practice of high-value new drug research and development .
-
22 ophthalmology category 1 new drugs are coming to Hengrui, 3 new drugs are expected to be launched
Time of Update: 2022-05-01
Among the new ophthalmic drugs currently under development by the company, KH906 eye drops, a class 1 new drug, has entered Phase I clinical trials for the treatment of corneal neovascularization; KH737 eye drops, which have been approved for clinical use, are used to delay the progression of myopia in children .
-
The net profit of 9 traditional Chinese medicine companies doubled, and Dong'e Ejiao became the "growth king"
Time of Update: 2022-05-01
Among them, four companies including Tasly and Pien Tze Huang have a net profit of over 2 billion yuan, and Jichuan Pharmaceutical, Qizheng Tibetan Medicine and Hongri Pharmaceutical also showed double-digit growth .
-
The government work report emphasizes: promote the centralized procurement of medicines and high-value medical consumables, strengthen the protection of rare disease drugs, and support the revitalization and development of traditional Chinese medicine...
Time of Update: 2022-05-01
At 9:00 a. m. on March 5, the fifth session of the 13th National People's Congress opened . The government work report pointed out that the past year was a landmark year in the history of the part
-
700,000 "high-priced drugs" dropped to 33,000!
Time of Update: 2022-05-01
According to statistics, there are currently more than 60 rare disease drugs approved for marketing in China, of which more than 40 have been included in the National Medical Insurance Drug List, involving 25 diseases .
-
60 kinds of compound preparations are amazing!
Time of Update: 2022-05-01
In recent years, the sales of compound calcium gluconate oral solution in Chinese urban physical pharmacies (unit: 10,000 yuan) Source: Minet China's urban physical pharmacy terminal competition pattern exceeds 1 billion star varieties, Chia Tai Tianqing, Kelun, Beite.
-
The gross profit margin is nearly 90%. How long can this medical equipment track last?
Time of Update: 2022-05-01
The absorbable dural (spinal) membrane patch achieved sales revenue of 158 million yuan, a year-on-year increase of 14.
The main domestic regenerative medical consumables include oral repair membrane, bone repair material, dura (spinal) membrane patch, hernia patch, etc.
-
2021 Medical Insurance Statistical Express, Fund Income and Expenditure, Medical Insurance Catalogue Adjustment, Centralized Procurement, DRG/DIP...
Time of Update: 2022-05-01
22 million people participated in the basic medical insurance for employees, an increase of 9.
109 billion yuan respectively, and the cumulative balance of basic medical insurance (including maternity insurance) at the end of the year will be 3,612.
-
15 drugs to be withdrawn from the Internet!
Time of Update: 2022-05-01
If there is any objection, the enterprise must appeal through the Jiangsu Provincial Public Resource Trading Platform (Drug Classified Procurement - Other - Revocation of Online Appeal (202203)) within the publicity period, and submit relevant certification materials .
-
What factors depend on the entry of innovative drugs into medical insurance?
Time of Update: 2022-05-01
In this case, among the anti-tumor and immunomodulatory agents in the 2021 edition of the negotiated catalogue, the average time interval between the approval of the market and the entry into the medical insurance of the varieties that entered the medical insurance through negotiation in 2017 was 6.
-
The National Health and Health Commission first proposed to standardize the establishment of branch campuses, and the development of one hospital and multiple districts needs to overcome three major difficulties
Time of Update: 2022-05-01
Soon, at the National Medical Management Work Conference held in February 2021, it was clearly pointed out that the research and introduction of policies to guide the development of large public hospitals in one hospital and multiple districts should not only control the scale expansion of individual institutions, but also guide the expansion and doubling of high-quality medical resources.
-
The reporter went to four places to investigate: it is better to open up the blocking points to facilitate the masses to seek medical treatment in different places
Time of Update: 2022-05-01
Han Qinghua, a member of the National Committee of the Chinese People's Political Consultative Conference and vice president of the First Hospital of Shanxi Medical University, said in an interview with reporters that the blocking point of this case is that policies such as medical insurance settlement for medical treatment in different places and hierarchical diagnosis and treatment are still being implemented, and further improvement and coordination are needed .
-
Medical device supervision realizes six new 2021 supervision work inventory
Time of Update: 2022-05-01
The regulatory department insists on reform and innovation, consolidates and expands the reform achievements of the review and approval system, establishes the registrant system, improves the clinical evaluation requirements, promotes the construction of professional and professional inspector teams, strengthens the quality risk supervision of the whole life cycle, and increases the penalties for illegal acts.
-
"Compilation of Medical Device Standard Catalogue (2022 Edition)" released
Time of Update: 2022-05-01
As of February 18, 2022, a total of 1,851 current medical device standards have been formulated and revised by the State Food and Drug Administration according to their responsibilities, including 235 national standards (91 mandatory standards, 144 recommended standards) and 1,616 industry standards.
-
How to prevent and combat fraud and embezzlement?
Time of Update: 2022-05-01
In order to further strengthen fund supervision and crack down on illegal acts that violate funds, the Ministry of Human Resources and Social Security recently announced a new version of the "Administrative Supervision Measures for Social Insurance Funds", which will come into force on March 18 .
-
3000 new stores in half a year!
Time of Update: 2022-05-01
In the process of visiting the top 100 chains in Jinan, Qingdao, Yantai and other cities, the reporter It is found that the competition among local pharmacies is very fierce, such as the listed chain Shuyu Mining's stores almost all over the province, and some regional leaders of small ones are also trying or have expanded to neighboring areas .
-
National Health and Health Commission: 67 newly negotiated drugs are successfully equipped in designated medical institutions
Time of Update: 2022-05-01
According to data from the National Health Commission, as of the end of January 2022, the negotiated drugs within the agreement period in the new version of the National Medical Insurance Drug Catalog were equipped in 154,700 designated medical institutions across the country .
